Franco Malanga

Title: Franco Malanga: Innovator in Neuromuscular Blocking Agents

Introduction

Franco Malanga is a notable inventor based in San Giuliano Milanese, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of neuromuscular blocking agents. His innovative work has led to advancements in medical treatments that enhance patient care.

Latest Patents

Franco Malanga holds a patent for a process for the purification of neuromuscular blocking agents. This patent describes a method for preparing neuromuscular blocking agents with an isoquinoline structure, such as atracurium besylate, doxacurium chloride, mivacurium chloride, and gantacurium chloride. The process involves chromatographic purification of their mixtures of isomers using silica modified by treatment with a tertiary amine or a corresponding quaternary ammonium compound. This innovative approach has the potential to improve the efficacy and safety of these important medical agents.

Career Highlights

Franco Malanga is associated with Farmabios S.p.a., a company that specializes in pharmaceutical products. His work at Farmabios has allowed him to focus on the development and refinement of neuromuscular blocking agents, contributing to the company's reputation in the pharmaceutical industry. His patent reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

Franco has collaborated with notable colleagues, including Claudio Gianluca Pozzoli and Vincenzo Redaelli. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceuticals.

Conclusion

Franco Malanga's contributions to the field of neuromuscular blocking agents exemplify the impact of innovation in medicine. His patent and work at Farmabios highlight the importance of research and development in improving healthcare solutions.